Evidence map›Paper›PMID 33371321›Full record

ArticleMolecules (Basel, Switzerland)2020

Chitosan Oligosaccharides Coupling Inhibits Bacterial Biofilm-Related Antibiotic Resistance against Florfenicol.

Xianghua Yuan, Jing Liu, Ruilian Li, Junlin Zhou, Jinhua Wei, Siming Jiao, Zhuo A Wang, Yuguang Du

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xianghua YuanCollege of Life Science, Sichuan Normal University, Chengdu 610101, China.
Jing LiuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Ruilian LiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0001-9952-6093
Junlin ZhouCollege of Life Science, Sichuan Normal University, Chengdu 610101, China.
Jinhua WeiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Siming JiaoState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Zhuo A WangState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0002-4707-036X
Yuguang DuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
Institute of Process Engineering · CNSichuan Normal University · CN

Funding

National Key Research and Development Program of China 2017YFD0502300National Natural Science Foundation of China 31670809
6 · The paper itself

Abstract

The formation of bacterial biofilms has increased the resistance of bacteria to various environmental factors and is tightly associated with many persistent and chronic bacterial infections. Herein we design a strategy conjugating florfenicol, an antibiotic commonly used in the treatment of

Indexed as

Anti-Bacterial AgentsBacterial InfectionsBiofilmsChitosanDrug Resistance, BacterialGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsOligosaccharidesPlanktonStreptococcusThiamphenicolAnti-Bacterial AgentsChitosanflorfenicolOligosaccharidesThiamphenicolantibiotic resistancebiofilmchitosan oligosaccharideflorfenicol

Identifiers

PMID33371321
PMCPMC7767115
OpenAlexW3116089072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.